News

The latest news about the CMCiB. For more news of research at the IGTP, please see our main website.

Fundación Mutua funds a Can Ruti project on the role of unknown viruses in head and neck tumours

Research teams from IGTP, ICO and IrsiCaixa have been granted funding from Fundación Mutua Madrileña to conduct the ERICA Project, which aims to investigate the role of viral infections in the development of squamous cell carcinoma of the head and neck.

Boehringer Ingelheim and the Germans Trias i Pujol Research Institute strengthen their collaboration in preclinical research

The agreement between Boehringer Ingelheim and IGTP builds on a collaboration that began in 2020 to improve understanding of cardio-renal-metabolic diseases and their interconnection, and now includes the development of a new line of research to assess the potential of novel molecules in this field.

The Innomed Awards highlight fifteen innovative biomedical projects in their second edition

The Innomed program, an initiative led and coordinated by the IGTP, has concluded the second edition of its GrowInn project incubator with the celebration of the Innomed Awards, which have gathered over 150 people and recognised five projects for their talent and determination.

Study led by IGTP reveals correlation between tuberculosis lesion transcriptomics and patients’ clinical parameters

Researchers from the Experimental Tuberculosis Unit (UTE) at the IGTP and the Germans Trias i Pujol University Hospital have published a study in Nature Communications in which, for the first time, the transcriptomic profile of human tuberculosis lung lesions is correlated with clinical data from the same patients.

Students from Sadako School and UAB Biomedicine visit the IGTP

On May, students from Sadako School and the Autonomous University of Barcelona (UAB) visited the IGTP as part of its educational outreach to promote science among young people.

A new mouse model allows for more accurate study of COVID-19 in humans

The study presents a new mouse model that more realistically mimics the disease caused by SARS-CoV-2 in humans, an essential tool for better understanding COVID.